The Human Cervix PrimaCell™ 4: Normal Cervical Endometrial Epithelial Cells is for rapid (7-10 days) isolation and growth of normal cervical endometrial epithelial cells from human endometrial tissues. This system features an optimal condition of tissue dissociation system, Cervix OptiTDS™ that yields 5-7 times of single cells more than most of the tissue dissociation protocols published in the literature. In addition, this system ensures a high viability of the target cells with improved gradient contained in the culture medium. With CHI's proprietary fibroblast inhibitory system, FibrOut™, cells are growing with minimal amount of the unwanted cells such as fibroblasts.

Human Cervix PrimaCell™ 4 System (Cat No. 2-96047):
Human Cervix PrimaCell™ 4 Normal Cervical Endometrial Epithelial Cells Protocols
Human Cervix Tissue Preparation Buffer 4: Normal Cervical Endometrial Epithelial Cells
Human Cervix OptiTDS™ 4: Tissue Dissociation System
Human Cervix FibrOut™: Fibroblast Inhibitory System (for 500 ml medium)
Human Cervix PrimaCell™ 4: Normal Cervical Endometrial Epithelial Cells Growth Medium
Human Cervix PrimaCell™ 4: Normal Cervical Endometrial Epithelial Cells Growth Supplements with Serum (for 500 ml medium)

References:

[1] Wu J, Wang L, He J, Zhu C. In vitro cytotoxicity of Cu2+, Zn2+, Ag+ and their mixtures on primary human endometrial epithelial cells. Contraception. 2012 May;85(5):509-18. Epub 2011 Nov 12.
[2] Evron A, Goldman S, Shalev E. Effect of primary human endometrial stromal cells on epithelial cell receptivity and protein expression is dependent on menstrual cycle stage. Hum Reprod. 2011 Jan;26(1):176-90. Epub 2010 Nov 23.